Clinical role of urinary low molecular weight proteins: Their diagnostic and prognostic implications

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue SUPPL. 241, 2008, Pages 95-98

  Guder, Walter G ^a   Hofmann, Walter ^a  

^a Städtisches Klinikum München GmbH ^*  (Germany)

Author keywords

1 microglobulin; 2 microglobulin; Bence Jones protein; Clara cell protein; Haemoglobinuria; Low molecular weight proteins in urine; Lysozyme; Myoglobinuria; Retinol binding globulin; Urine enzymes

Indexed keywords

ALPHA 1 MICROGLOBULIN; BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; HEMOGLOBIN; IMMUNOGLOBULIN LIGHT CHAIN; LOW MOLECULAR WEIGHT PROTEIN; LYSOZYME; MYOGLOBIN; RETINOL BINDING PROTEIN;

BETA 2 MICROGLOBULIN URINE LEVEL; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; ENZYMURIA; GLOMERULUS FILTRATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PROTEINURIA; TUBULAR DYSFUNCTION; URINALYSIS; ARTICLE; KIDNEY DISEASE; MOLECULAR WEIGHT; PROGNOSIS;

BIOLOGICAL MARKERS; HUMANS; KIDNEY DISEASES; MOLECULAR WEIGHT; PROGNOSIS; PROTEINURIA;

EID: 45849106086     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802150174     Document Type: Conference Paper

References (24)

1. Bohle A, Mackemsen S, Gise H. The consequence of tubulointerstitial changes for renal function in glomerulonephritis. In: Americo A, Cortelli P, Masry S, editors. Tubulointerstitial nephropathies. Boston: Kluwer; 1991. pp 29-40.
2. Thomas L, Fateh-Moghadam A, Guder WG, Hofmann W, Reiber H, Lammers M. Proteindiagnostik. Behring Diagnostika; 1981.
3. Jung K, Mattenheimer H, Burchardt U. Urinary enzymes. Berlin-Heidelberg: Springer; 1992.
4. Bradwell AR, Mead GP, Carr-Smith HD. Serum free light chain analysis, 4th edn. A. R. Bradwell, Birmingham; 2006.
5. Hofmann W, Garbrecht M, Bradwell AR, Guder WG. A new concept of Bence Jones proteinuria in patients with monoclonal gammopathy. Clin Lab 2004;50:181-5.
6. Evrin PE, Wibell L. Serum levels and urinary excretion of beta-2-microglobulin in apparently healthy subjects. Scand J Clin Lab Invest. 1972;29:69-74.
7. Hardwicke J. Laboratory aspects of proteinuria in human disease. Clin Nephrol 1975;3:37-41.
8. Balant L, Mulli J-C, Fabre J. Urinary Protein analysis with sodium dodecylsulfate polyacrylaminde gel electrophoresis - a comparison with other analytical techniques. Clin Chim Acta 1973;54:27-37.
9. Hofmann W, Guder WG. A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 1989;27:589-600.
10. Bernard AM, Moreau D, Lauwerys R. Comparison of retinol binding protein and b2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 1982;126:1-7.
11. Burchardt U, Haschen RJ, Krosch H. Clinical usefulness of enzyme determinations in urine. In: Dubach UC, Schmidt U. Diagnostic significance of enzymes and proteins in urine. Bern, Stuttgart, Vienna: Hans Huber; 1979. pp 106-11.
12. Everaert K, Delange I, Vade Wide C, et al. The urinary a1-microglobulin: Its measurement and clinical significance. J Clin Lab Med 1998;36:309-15.
13. Bernard AM, Thielemans NO, Lauwerys RR. Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction. Kidney Int 1994;46 Suppl 47:34-7.
14. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. 2003;14:2534-43.
15. Vaidya VS, Ramiez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006;290:517-29.
16. Itoh Y, Kawai T. Human a1-microglobulin: Its measurement and clinical significance. J Clin Lab Anal 1990;4:376-84.
17. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992;38:20-7.
18. Herget-Rosenthal H, Poppen D, Hüsing J, Marggraf G, Pietruck F, Jacob H-G, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004;50:552-8.
19. 2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol 2005;16:169-74.
20. Hofmann W, Edel H, Guder WG. A mathematical equation to differentiate overload proteinuria from tubulo-interstitial involvement in glomerular diseases. Clin Nephrol 1995;44:28-81.
21. Guder WG, Hofmann W. Challenges in urine analysis and glomerular filtration measurement for early detection of kidney diseases. Farm Vestn (Pharm J Slovenia) 2004;55:285-6.
22. Guder WG, Hofmann W. Urine a1-microglobulin as a predictive marker to differentiate diabetic nephropathy from other causes of albuminuria. Euromedlab Barcelona. Clin Chem Lab Med 2003;41:253 [abstract].
23. Hofmann W, Ruth D, Guder WG. Urine protein differentiation and Protis, a new expert system for its interpretation. Riv Med Lab-JLM 2003;4:67-8.
24. Kouri T, Fogazzi G, Gant V, Hallander H, Hofmann W, Guder WG. European Urinalysis Guidelines. Scand J Clin Lab Invest 2000;60 Suppl 231.